Mr David Ian Highton

BRITISHUNITED KINGDOMBorn July 1968

Risk Flags

Director of 1 company with insolvency proceedings

Current Appointments
23

Pfizer Leasing Uk Limited

director · Since 13/04/2026

Active
Zihipp Ltd

director · Since 13/11/2025

Active
Metsera Limited

director · Since 13/11/2025

Active - Proposal to Strike off
Mpp Trustee Limited

director · Since 29/08/2024

Active
Seagen U.K. Ltd.

director · Since 18/12/2023

Liquidation
Global Blood Therapeutics Uk Limited

director · Since 24/04/2023

Resapp Health (Uk) Limited

director · Since 03/11/2022

Pfizer Limited

director · Since 23/06/2022

Active
Pfizer R&D Uk Limited

director · Since 23/06/2022

Active
Reviral Limited

director · Since 09/06/2022

Liquidation
Haptogen Limited

director · Since 08/02/2021

Hospira Uk Limited

director · Since 08/02/2021

Active
Pfizer Consumer Healthcare

director · Since 08/02/2021

Active
John Wyeth & Brother Limited

director · Since 08/02/2021

Active
Pharmacia Limited

director · Since 08/02/2021

Active
Neusentis Limited

director · Since 08/02/2021

Thiakis Limited

director · Since 08/02/2021

Pfizer Development Services (Uk) Limited

director · Since 08/02/2021

Active
Wyeth Europa Limited

director · Since 08/02/2021

Hospira Aseptic Services Limited

director · Since 06/08/2020

G.D.Searle & Co.Limited

director · Since 03/07/2017

Powderject Research Limited

director · Since 03/07/2017

Pfizer Specialty Uk Limited

director · Since 03/07/2017

Liquidation

Insolvency Proceedings

Pfizer Specialty Uk Limited

members voluntary liquidation

members

Summary

Current roles23
Former roles0
NationalityBRITISH
Based inUNITED KINGDOM
DOBBorn July 1968
Risk flags Medium risk

Financial FootprintActive cos.

Combined net worth£44.2m
Total employees21

Based on latest filed accounts for 3 of 23 active companies.

Data sourced from Companies House public register. Financial data from filed accounts. Updated as filings are processed.